About the Conference
The 21st International Conference on Emerging Frontiers in Cancer Research: Molecular Mechanisms to Personalized Treatments is an international scientific meeting dedicated to advancing knowledge, collaboration, and innovation in cancer research and care. The conference will be held from 29–31 October 2026 at Gautam Buddha University, Greater NOIDA, India and Shiv Nadar Institution of Eminence, Deemed to be University, Greater NOIDA, India.
The conference is being organised by Gautam Buddha University, Greater NOIDA, India, in association with Shiv Nadar Institute of Eminence, Greater NOIDA, India, Roswell Park Comprehensive Cancer Center, Buffalo, USA, Rutgers Health New Jersey Medical School, USA, and Cancer Research and Care Academy, New Delhi, India.
Conference Overview
Cancer research is entering a transformative era. Advances in molecular biology, genomics, immunology, systems medicine, artificial intelligence, and precision oncology are reshaping how cancer is understood, diagnosed, prevented, and treated. The field is moving from generalized treatment approaches toward more personalised, data-driven, and mechanism-based strategies that consider the unique molecular profile of each tumour and patient.
This conference aims to bring together leading scientists, clinicians, researchers, academicians, students, industry professionals, and young investigators from India and abroad to discuss emerging discoveries and translational advances in cancer biology and therapy. It will provide a multidisciplinary platform for scientific exchange across basic, translational, clinical, computational, and integrative areas of oncology.
Theme
The central theme of the conference is:
Emerging Frontiers in Cancer Research: Molecular Mechanisms to Personalized Treatments
The theme reflects the need to connect fundamental discoveries in cancer biology with innovative therapeutic approaches, including targeted therapies, immunotherapies, cell-based therapies, theranostics, radiation strategies, chemoprevention, natural and synthetic agents, systems medicine, and AI-driven cancer research.
Scientific Focus
The conference will cover a wide range of contemporary and emerging areas, including:
Emerging trends and new therapeutic targets in cancer
Small molecules in cancer prevention and therapeutics
Cell death modalities in cancer development and treatment
Basic and translational cancer research
Cancer stemness and resistance to therapy
Novel approaches for radiation therapies
Targeting mitochondria for cancer prevention and treatment
Precision oncology and personalized cancer treatment approaches
Ayurveda and integrative medicine in cancer care and inflammatory diseases
Cancer chemoprevention using natural, herbal, and synthetic agents
Artificial Intelligence and Machine Learning in cancer research
Systems medicine and cancer
Objectives
The conference aims to:
Promote high-quality scientific discussion on recent advances in cancer research.
Encourage collaboration between basic scientists, clinicians, translational researchers, and industry experts.
Highlight emerging molecular mechanisms that influence cancer initiation, progression, metastasis, treatment response, and resistance.
Explore new strategies in cancer prevention, diagnosis, treatment, and personalised care.
Provide a platform for young researchers and students to present their work and interact with national and international experts.
Strengthen academic and research partnerships between Indian and international institutions.
Support the translation of laboratory discoveries into clinically meaningful cancer care strategies.
Organising Institutions
The conference is supported by a strong academic and research network. Gautam Buddha University and Shiv Nadar Institute of Eminence provide the institutional foundation for the meeting in Greater NOIDA, while Roswell Park Comprehensive Cancer Center and Rutgers Health New Jersey Medical School bring significant international scientific engagement. Cancer Research and Care Academy, New Delhi, India, also contributes to the wider cancer research and care mission associated with the conference.
The organising leadership includes Prof. Rana P. Singh as Patron, with national and international convenors and co-convenors representing leading institutions in cancer biology, biotechnology, life sciences, and translational research.
Legacy and Continuity
This edition continues a long-standing academic effort to create meaningful platforms for discussion in cancer research. The conference series has previously completed 20 conferences, and the 21st edition builds on that experience with a renewed focus on molecular mechanisms, translational science, and personalised treatment approaches.
Cancer Research and Care Academy has been associated with this broader scientific journey, supporting the spirit of sustained dialogue, collaboration, and knowledge-sharing in cancer research and care. This continuity gives the conference both a strong legacy and a forward-looking purpose.
Who Should Attend
The conference is designed for:
Cancer biologists
Molecular biologists
Clinicians and oncologists
Translational researchers
Biotechnology and life sciences faculty
PhD scholars, postdoctoral fellows, and students
Public health and epidemiology researchers
Computational biology, AI, and data science researchers
Industry professionals working in cancer therapeutics, diagnostics, and healthcare innovation
Young scientists interested in emerging areas of oncology
Expected Outcomes
The conference is expected to create opportunities for scientific networking, research collaboration, student mentoring, and exchange of new ideas across disciplines. It will help participants understand recent developments in cancer mechanisms, therapeutic innovation, precision oncology, integrative approaches, and data-driven cancer research.
By connecting molecular discoveries with personalised treatments, the conference aims to contribute to the larger goal of improving cancer prevention, diagnosis, treatment, and patient care.